Clinical relevance and therapeutic potential of IL-38 in immune and non-immune-related disorders
European Cytokine Network · 01.09.2022 · 33 (3) · 54-69
DOI: 10.1684/ecn.2022.0480 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Cytokine Network, erschienen am 01.09.2022. Verfasst von Mohammad Reza Haghshenas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Interleukin-17, COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
- Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
Zitieren
APA
Haghshenas, M. R., Zamir, M. R., Sadeghi, M., Fattahi, M. J., Mirshekari, K., & Ghaderi, A. (2022). Clinical relevance and therapeutic potential of IL-38 in immune and non-immune-related disorders. European Cytokine Network, 33(3), 54-69. https://doi.org/10.1684/ecn.2022.0480
Vancouver
Haghshenas MR, Zamir MR, Sadeghi M, Fattahi MJ, Mirshekari K, Ghaderi A. Clinical relevance and therapeutic potential of IL-38 in immune and non-immune-related disorders. European Cytokine Network. 2022;33(3):54-69. doi:10.1684/ecn.2022.0480
BibTeX
@article{Haghshenas2022,
author = {Haghshenas, Mohammad Reza and Zamir, Mina Roshan and Sadeghi, Mahboubeh and Fattahi, Mohammad Javad and Mirshekari, Kimia and Ghaderi, Abbas},
title = {Clinical relevance and therapeutic potential of IL-38 in immune and non-immune-related disorders},
journal = {European Cytokine Network},
year = {2022},
volume = {33},
number = {3},
pages = {54--69},
doi = {10.1684/ecn.2022.0480}
}
EUVIMED